OPGN - オプジェン (OpGen Inc.) オプジェン

 OPGNのチャート


 OPGNの企業情報

symbol OPGN
会社名 OpGen Inc (オプジェン)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical Specialities  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 オプジェン(OpGen Inc.)は生命科学のための光学的マッピングソリューションの提供に従事する米国の会社である。同社は微生物、酵母、及び真菌ゲノムアーキテクチャの分析ため光学的マッピングサービスを提供する。その光学的マッピング技術は、生命科学、臨床的及び食品微生物学、生命科学、疫学、薬理学、微生物法医学、製造品質管理、及び応用研究アプリケーションに応用される。同社のマップ解析ソフトウェアモジュールは、100Mb以内の微生物サンプルとゲノムため分析を提供する「Argus」全ゲノムマッピングシステムを含む。   オプジェンは、米国のバイオ企業。医療提供者を支援するために、分子テストや生物情報学を用いて、多剤抵抗性細菌感染症向けに初期商用段階の医薬品を提供。また、全遺伝子解読のための製品やサ―ビスを提供するほか、生命科学のための微生物、植物、動物およびヒト遺伝子の分析を手掛ける。   
本社所在地 708 Quince Orchard Road Suite 160 Gaithersburg MD 20878 USA
代表者氏名 Evan Jones エヴァンジョーンズ
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 240-813-1260
設立年月日 36892
市場名 NASDAQ Small Cap
ipoyear 2015年
従業員数
url www.opgen.com
nasdaq_url https://www.nasdaq.com/symbol/opgn
adr_tso
EBITDA EBITDA(百万ドル) -11.73453
終値(lastsale) 1.9899
時価総額(marketcap) 12359820.1023
時価総額 時価総額(百万ドル) 8.57156
売上高 売上高(百万ドル) 3.37115
企業価値(EV) 企業価値(EV)(百万ドル) 3.09665
当期純利益 当期純利益(百万ドル) -12.61360
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 OpGen Inc revenues increased 11% to $1.6M. Net loss decreased 31% to $6.4M. Revenues reflect Collaboration revenue increase from $27K to $359K. Lower net loss reflects Interest and other income increase from $0K to $5K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$5.67 to -$1.32.

 OPGNのテクニカル分析


 OPGNのニュース

   Thinking about buying stock in OpGen, GameStop, Johnson & Johnson, BioNano Genomics, or SINTX Technologies?  2021/03/10 13:30:00 PR Newswire
NEW YORK, March 10, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OPGN, GME, JNJ, BNGO, and SINT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Why Immunovant, Anchiano, OpGen Are Rallying Today  2021/03/08 18:09:14 Benzinga
Immunovant, Inc. (NASDAQ: IMVT ), Anchiano Therapeutics Ltd. (NASDAQ: ANCN ) and OpGen, Inc. (NASDAQ: OPGN ) are among the biggest healthcare gainers on Monday. Immunovant Rallies On Buyout Offer: Biotech holding company Roivant Sciences, which is planning an initial public offering, revealed in a filing with the SEC that it intends to make an offer for acquiring all of the issued shares that it does not currently own in its subsidiary Immunovant. Roivant currently has a 57.5% stake in Immunovant, a clinical-stage biopharma that focuses on developing therapies for autoimmune diseases. Roivant said it expects that any potential transaction would be at a per … Full story available on Benzinga.com
   OPGN Stock: 9 Things for OpGen Investors to Know as Shares Skyrocket  2021/03/08 16:59:25 InvestorPlace
OpGen (OPGN) stock is flying high on Monday following results from a study published in a peer-reviewed publication concerning coronavirus.
   The state of bioinformatics in the fight against AMR  2021/01/27 14:15:00 EPM Magazine
Oliver Schacht, CEO of OpGen, Inc., examines the potential of bioinformatics in helping to fight antimicrobial resistance.
   EFFECT - OPGEN INC (0001293818) (Filer) - Stocks News Feed  2020/12/07 05:20:53 Stocks News Feed
Accepted 2020-12-07 00:20:53 Documents Stock Market Shirts | Stock Trading Mugs | Stock Trader Decor | Investing Books 1 Effectiveness Date 2020-12-04 Registration Form S-3 Document Format Files Mailing Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878 Business Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878 240-813-1260 OPGEN INC (Filer) CIK:… Read More »EFFECT – OPGEN INC (0001293818) (Filer)
   Thinking about buying stock in OpGen, GameStop, Johnson & Johnson, BioNano Genomics, or SINTX Technologies?  2021/03/10 13:30:00 PR Newswire
NEW YORK, March 10, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OPGN, GME, JNJ, BNGO, and SINT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Why Immunovant, Anchiano, OpGen Are Rallying Today  2021/03/08 18:09:14 Benzinga
Immunovant, Inc. (NASDAQ: IMVT ), Anchiano Therapeutics Ltd. (NASDAQ: ANCN ) and OpGen, Inc. (NASDAQ: OPGN ) are among the biggest healthcare gainers on Monday. Immunovant Rallies On Buyout Offer: Biotech holding company Roivant Sciences, which is planning an initial public offering, revealed in a filing with the SEC that it intends to make an offer for acquiring all of the issued shares that it does not currently own in its subsidiary Immunovant. Roivant currently has a 57.5% stake in Immunovant, a clinical-stage biopharma that focuses on developing therapies for autoimmune diseases. Roivant said it expects that any potential transaction would be at a per … Full story available on Benzinga.com
   OPGN Stock: 9 Things for OpGen Investors to Know as Shares Skyrocket  2021/03/08 16:59:25 InvestorPlace
OpGen (OPGN) stock is flying high on Monday following results from a study published in a peer-reviewed publication concerning coronavirus.
   The state of bioinformatics in the fight against AMR  2021/01/27 14:15:00 EPM Magazine
Oliver Schacht, CEO of OpGen, Inc., examines the potential of bioinformatics in helping to fight antimicrobial resistance.
   EFFECT - OPGEN INC (0001293818) (Filer) - Stocks News Feed  2020/12/07 05:20:53 Stocks News Feed
Accepted 2020-12-07 00:20:53 Documents Stock Market Shirts | Stock Trading Mugs | Stock Trader Decor | Investing Books 1 Effectiveness Date 2020-12-04 Registration Form S-3 Document Format Files Mailing Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878 Business Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878 240-813-1260 OPGEN INC (Filer) CIK:… Read More »EFFECT – OPGEN INC (0001293818) (Filer)

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 オプジェン OPGN OpGen Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)